GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea · Delayed Price · Currency is KRW 12,950
+30 (0.23%)
At close: Jan 27, 2026
GFC Life Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Net Income | 1,617 | -2,863 | 448.7 | -499.99 | -935.35 |
Depreciation & Amortization | 903.41 | 762.56 | 794.15 | 461.4 | 267.76 |
Loss (Gain) From Sale of Assets | -172.58 | - | -835.46 | -125.63 | -3.17 |
Asset Writedown & Restructuring Costs | 42.72 | 96.86 | - | - | - |
Loss (Gain) From Sale of Investments | -54.29 | -43.9 | -69.65 | - | - |
Loss (Gain) on Equity Investments | - | 323.54 | -217.23 | -1,126 | -394.96 |
Stock-Based Compensation | 71.19 | 68.22 | - | - | - |
Provision & Write-off of Bad Debts | 33.95 | -17.43 | 0.25 | 98.28 | 3.27 |
Other Operating Activities | -118.28 | 2,689 | 25.34 | 717.6 | 260.71 |
Change in Accounts Receivable | 83.48 | -31.51 | -53.89 | 280.62 | -327.39 |
Change in Inventory | 29.81 | -251.58 | 409.69 | -473.31 | 136.24 |
Change in Accounts Payable | -127.5 | -9.87 | 125.81 | -61.43 | 287.76 |
Change in Unearned Revenue | - | -7.41 | 0.38 | -183.42 | -79.82 |
Change in Income Taxes | - | -15.94 | -99.12 | - | -25.35 |
Change in Other Net Operating Assets | -1,368 | -40.91 | -939.38 | 156.62 | 150.64 |
Operating Cash Flow | 941.21 | 659.42 | -410.42 | -754.8 | -659.66 |
Operating Cash Flow Growth | 42.73% | - | - | - | - |
Capital Expenditures | -584.07 | -2,593 | -3,597 | -6,592 | -1,272 |
Sale of Property, Plant & Equipment | 3,184 | - | 1,199 | 906.71 | 12.05 |
Cash Acquisitions | 31.1 | - | 1,954 | - | - |
Sale (Purchase) of Intangibles | -67.17 | -13.73 | -15.85 | -3.68 | -58.98 |
Investment in Securities | 627.17 | -648.42 | -247.34 | -134.14 | 335.37 |
Other Investing Activities | -214.01 | 50.68 | -0 | 720 | - |
Investing Cash Flow | 2,977 | -3,139 | -1,157 | -5,773 | -1,263 |
Short-Term Debt Issued | 1,516 | 2,166 | 500 | - | - |
Long-Term Debt Issued | 770 | 1,100 | 2,200 | 5,000 | 892.31 |
Total Debt Issued | 2,286 | 3,266 | 2,700 | 5,000 | 892.31 |
Short-Term Debt Repaid | -2,012 | -1,086 | - | - | - |
Long-Term Debt Repaid | -3,148 | -336.12 | -1,396 | -1,332 | -896.51 |
Total Debt Repaid | -5,160 | -1,422 | -1,396 | -1,332 | -896.51 |
Net Debt Issued (Repaid) | -2,874 | 1,844 | 1,304 | 3,668 | -4.2 |
Issuance of Common Stock | - | - | - | 1,500 | - |
Repurchase of Common Stock | - | -200 | - | - | - |
Financing Cash Flow | -2,874 | 1,644 | 1,304 | 5,168 | -4.2 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - |
Net Cash Flow | 1,044 | -835.31 | -263.64 | -1,360 | -1,927 |
Free Cash Flow | 357.14 | -1,934 | -4,007 | -7,347 | -1,931 |
Free Cash Flow Margin | 2.60% | -14.51% | -33.65% | -84.65% | -26.97% |
Free Cash Flow Per Share | 344.54 | -1865.79 | -3867.17 | -14179.32 | -1862.49 |
Levered Free Cash Flow | -236.89 | -464.03 | -3,086 | -7,613 | -1,434 |
Unlevered Free Cash Flow | -100.59 | -335.61 | -2,949 | -7,530 | -1,384 |
Change in Working Capital | -1,382 | -357.22 | -556.51 | -280.92 | 142.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.